| Sun Behavioral Health | |
| 820 Dolwick Drive, Erlanger, Kentucky 41018 | |
| (859) 429-5188 | |
| Not Available |
| Name | Sun Behavioral Health |
|---|---|
| Type | Psychiatric Hospital |
| Location | 820 Dolwick Drive, Erlanger, Kentucky |
| Ownership | Voluntary non-profit - Private |
| Emergency Services | No |
| Medicare ID (CCN) | 184006 |
| NPI Number | 1417486325 |
| Organization Name | NORTHERN KENTUCKY BEHAVIORAL, LLC |
| Doing Business As | SUN BEHAVIORAL HEALTH |
| Address | 820 Dolwick Drive, Erlanger, KY 41018 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 732-747-1800 |
News Archive
Allergan plc today announced that SAPHRIS (asenapine) 2.5 mg sublingual (placed under the tongue) black-cherry flavored tablets are available in pharmacies throughout the U.S. In March 2015, the U.S. Food and Drug Administration approved SAPHRIS for the acute treatment of manic or mixed episodes associated with bipolar I disorder in pediatric patients (ages 10 – 17).
An international team of molecular scientists have discovered that star ascidians, also known as sea squirts, have pacemaker cells similar to that of the human heart. The research, published in the JEZ A: Ecological Genetics and Physiology, may offer a new insight into the early evolution of the heart as star ascidians are one of the closest related invertebrates to mammals.
Global Health Corps and DSM called attention to the growing issue of micronutrient deficiency in the U.S. in a press conference with Barbara Bush, CEO of GHC, Hugh Welsh, President of DSM North America, Newark Municipal Council President Mildred Crump and Jim White, Executive Director of Covenant House New Jersey.
Therefore, scientists functionalize nanoparticles to act against these pathogenic viruses in a clinical strategy. In a recent review published in the journal Microbial Pathogenesis, researchers look at the novel solutions against zoonotic viruses provided by nanotechnology.
XBiotech announced today enrollment of the first patient into its Phase III trial of Xilonix. The Pivotal study is designed to improve health and survival of late stage colorectal cancer patients with associated cachexia.
› Verified 8 days ago
| NPI Number | 1891213179 |
| Organization Name | SUN BEHAVIORAL DELAWARE, LLC |
| Doing Business As | SUN BEHAVIORAL DELAWARE |
| Address | 21655 Biden Ave, Georgetown, DE 19947 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 732-747-1800 |
News Archive
Allergan plc today announced that SAPHRIS (asenapine) 2.5 mg sublingual (placed under the tongue) black-cherry flavored tablets are available in pharmacies throughout the U.S. In March 2015, the U.S. Food and Drug Administration approved SAPHRIS for the acute treatment of manic or mixed episodes associated with bipolar I disorder in pediatric patients (ages 10 – 17).
An international team of molecular scientists have discovered that star ascidians, also known as sea squirts, have pacemaker cells similar to that of the human heart. The research, published in the JEZ A: Ecological Genetics and Physiology, may offer a new insight into the early evolution of the heart as star ascidians are one of the closest related invertebrates to mammals.
Global Health Corps and DSM called attention to the growing issue of micronutrient deficiency in the U.S. in a press conference with Barbara Bush, CEO of GHC, Hugh Welsh, President of DSM North America, Newark Municipal Council President Mildred Crump and Jim White, Executive Director of Covenant House New Jersey.
Therefore, scientists functionalize nanoparticles to act against these pathogenic viruses in a clinical strategy. In a recent review published in the journal Microbial Pathogenesis, researchers look at the novel solutions against zoonotic viruses provided by nanotechnology.
XBiotech announced today enrollment of the first patient into its Phase III trial of Xilonix. The Pivotal study is designed to improve health and survival of late stage colorectal cancer patients with associated cachexia.
› Verified 8 days ago
News Archive
Allergan plc today announced that SAPHRIS (asenapine) 2.5 mg sublingual (placed under the tongue) black-cherry flavored tablets are available in pharmacies throughout the U.S. In March 2015, the U.S. Food and Drug Administration approved SAPHRIS for the acute treatment of manic or mixed episodes associated with bipolar I disorder in pediatric patients (ages 10 – 17).
An international team of molecular scientists have discovered that star ascidians, also known as sea squirts, have pacemaker cells similar to that of the human heart. The research, published in the JEZ A: Ecological Genetics and Physiology, may offer a new insight into the early evolution of the heart as star ascidians are one of the closest related invertebrates to mammals.
Global Health Corps and DSM called attention to the growing issue of micronutrient deficiency in the U.S. in a press conference with Barbara Bush, CEO of GHC, Hugh Welsh, President of DSM North America, Newark Municipal Council President Mildred Crump and Jim White, Executive Director of Covenant House New Jersey.
Therefore, scientists functionalize nanoparticles to act against these pathogenic viruses in a clinical strategy. In a recent review published in the journal Microbial Pathogenesis, researchers look at the novel solutions against zoonotic viruses provided by nanotechnology.
XBiotech announced today enrollment of the first patient into its Phase III trial of Xilonix. The Pivotal study is designed to improve health and survival of late stage colorectal cancer patients with associated cachexia.
› Verified 8 days ago
Sun Behavioral Health Psychiatric Hospital Location: 820 Dolwick Drive, Erlanger, Kentucky 41018 Phone: (859) 429-5188 |